This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

EDDA Technology Demonstrates The IQQA® Platform Of Real-time Interactive Fully 3D Quantitative Solutions For Disease-Centralized Patient Management













PRINCETON, N.J., Nov. 21, 2012 /PRNewswire/ -- EDDA Technology announced today that the company will demonstrate the generalization of its proven technologies of Real-time Interactive Fully 3D Quantitative Imaging in an enhanced IQQA Platform at the 98th Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA).  

The enhanced IQQA Platform answers to the challenge of maximizing the potential of imaging in coordinating an optimal workflow involving multiple stakeholders along the cycle of patient care, including radiologists, interventional radiologists, surgeons, and oncologists. The decision support provided by IQQA covers the full range of disease-centralized patient management in the abdominal and thoracic areas, from detection, diagnosis, pre-treatment planning, to intra-operative navigation, and post-treatment follow up.



A market-proven product of the platform, IQQA ®-Liver for 3D real-time quantitative planning and assessment, is currently used by radiologists and surgeons worldwide in liver surgery, transplantation, and interventional centers.  Substantial time saving and improved care was demonstrated in over 4,000 cases using IQQA-Liver in hospitals since the first commercial system installation in Q2 2009.  

Real-time interactive applications with fully 3D capabilities are the prerequisite of strong clinical decision support from imaging. The same proprietary technology behind IQQA ®-Liver has now been extended to other organs in thoracic and abdominal application areas; to offer physicians real-time quantitative decision support that goes well beyond the 3D visualization domain. It enables physicians to utilize the quantitative information of the organ, lesion, vessels, and ducts, as well as the quantified spatial relations among these anatomies of interests, to make their own individualized decision based upon own knowledge and experience in a user-friendly real-time interactive way, thus improving efficiency, and patient care.  

IQQA®-Guide (work-in-progress) further brings the Real-time Interactive Fully Quantitative technology into the operating room by offering real-time 3D image guidance for abdominal and thoracic biopsy, interventional procedure and surgery. IQQA-Guide utilizes a 3D map of individualized anatomic representations extracted from multi-modality image datasets. Through sophisticated registration algorithms and state-of-the-art electromagnetic tracking, it provides real-time tracking and referencing to anatomic features of interest in 3D. As a result, physicians are supported to "see in depth" beyond the anatomy surface during a procedure, and to quantitatively locate, assess, and adjust the position of instruments relative to the full patient-specific 3D anatomy of lesion, vessels, organs and segments.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 18,080.14 +21.45 0.12%
S&P 500 2,117.69 +4.76 0.23%
NASDAQ 5,092.0850 +36.0220 0.71%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs